<VariationArchive VariationID="336471" VariationName="NM_000233.4(LHCGR):c.50_55dup (p.Leu17_Gln18dup)" VariationType="Duplication" Accession="VCV000336471" Version="14" RecordType="classified" NumberOfSubmissions="8" NumberOfSubmitters="6" DateLastUpdated="2024-05-08" DateCreated="2016-12-06" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="287413" VariationID="336471">
      <GeneList>
        <Gene Symbol="LHCGR" FullName="luteinizing hormone/choriogonadotropin receptor" GeneID="3973" HGNC_ID="HGNC:6585" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2p16.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="48686774" stop="48755724" display_start="48686774" display_stop="48755724" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="48913912" stop="48982879" display_start="48913912" display_stop="48982879" Strand="-" />
          </Location>
          <OMIM>152790</OMIM>
        </Gene>
        <Gene Symbol="STON1-GTF2A1L" FullName="STON1-GTF2A1L readthrough" GeneID="286749" HGNC_ID="HGNC:30651" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2p16.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="48529925" stop="48776519" display_start="48529925" display_stop="48776519" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="48757063" stop="49003655" display_start="48757063" display_stop="49003655" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000233.4(LHCGR):c.50_55dup (p.Leu17_Gln18dup)</Name>
      <CanonicalSPDI>NC_000002.12:48755616:GCTGCAGC:GCTGCAGCTGCAGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2p16.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="48755616" stop="48755617" display_start="48755616" display_stop="48755617" variantLength="6" positionVCF="48755616" referenceAlleleVCF="G" alternateAlleleVCF="GGCTGCA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="48982755" stop="48982756" display_start="48982755" display_stop="48982756" variantLength="6" positionVCF="48982755" referenceAlleleVCF="G" alternateAlleleVCF="GGCTGCA" />
      </Location>
      <OtherNameList>
        <Name>LHCGR, LEU-GLN INS, CODON 19-20</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.48982758_48982763dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.48982758_48982763dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.48755619_48755624dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.48755619_48755624dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008193.2" sequenceAccession="NG_008193" sequenceVersion="2" change="g.5120_5125dup">
            <Expression>NG_008193.2:g.5120_5125dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033050.2" sequenceAccession="NG_033050" sequenceVersion="2" change="g.230695_230700dup">
            <Expression>NG_033050.2:g.230695_230700dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000233.4" sequenceAccession="NM_000233" sequenceVersion="4" change="c.50_55dup" MANESelect="true">
            <Expression>NM_000233.4:c.50_55dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000224.2" sequenceAccession="NP_000224" sequenceVersion="2" change="p.Leu17_Gln18dup">
            <Expression>NP_000224.2:p.Leu17_Gln18dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001198593.2" sequenceAccession="NM_001198593" sequenceVersion="2" change="c.3442-20661_3442-20656dup">
            <Expression>NM_001198593.2:c.3442-20661_3442-20656dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA1653491" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="152790.0017" DB="OMIM" />
        <XRef Type="rs" ID="71245621" DB="dbSNP" />
      </XRefList>
      <GlobalMinorAlleleFrequency Value="0.14457" Source="1000 Genomes Project" MinorAllele="GCTGCAGCTGCAGC" />
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000233.4(LHCGR):c.50_55dup (p.Leu17_Gln18dup) AND Hypergonadotropic hypogonadism" Accession="RCV000283585" Version="5">
        <ClassifiedConditionList TraitSetID="23573">
          <ClassifiedCondition DB="MedGen" ID="C0948896">Hypergonadotropic hypogonadism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-06-14" SubmissionCount="1">Benign</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000233.4(LHCGR):c.50_55dup (p.Leu17_Gln18dup) AND Leydig cell agenesis" Accession="RCV000319880" Version="5">
        <ClassifiedConditionList TraitSetID="3970">
          <ClassifiedCondition DB="MedGen" ID="C0266432">Leydig cell agenesis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-06-14" SubmissionCount="1">Benign</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000233.4(LHCGR):c.50_55dup (p.Leu17_Gln18dup) AND not specified" Accession="RCV000303287" Version="6">
        <ClassifiedConditionList TraitSetID="9590">
          <ClassifiedCondition DB="MedGen" ID="CN169374">not specified</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2017-07-26" SubmissionCount="3">Benign</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000233.4(LHCGR):c.50_55dup (p.Leu17_Gln18dup) AND Gonadotropin-independent familial sexual precocity" Accession="RCV000378063" Version="5">
        <ClassifiedConditionList TraitSetID="3969">
          <ClassifiedCondition DB="MedGen" ID="C0342549">Gonadotropin-independent familial sexual precocity</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-06-14" SubmissionCount="1">Benign</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000233.4(LHCGR):c.50_55dup (p.Leu17_Gln18dup) AND Luteinizing hormone/choriogonadotropin receptor, lq variant" Accession="RCV002270219" Version="1">
        <ClassifiedConditionList TraitSetID="3974">
          <ClassifiedCondition>Luteinizing hormone/choriogonadotropin receptor, lq variant</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000233.4(LHCGR):c.50_55dup (p.Leu17_Gln18dup) AND not provided" Accession="RCV002057704" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-29" SubmissionCount="1">Benign</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-29" NumberOfSubmissions="8" NumberOfSubmitters="6" DateCreated="2016-12-06" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Benign</Description>
        <Citation Type="general">
          <ID Source="PubMed">12679452</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2244890</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7556872</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9851790</ID>
        </Citation>
        <DescriptionHistory Dated="2022-07-29">
          <Description>Benign</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-07-29">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="23573" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="21943" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Hypergonadotropic hypogonadism</ElementValue>
                <XRef ID="HP:0000815" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0948896" DB="MedGen" />
              <XRef Type="primary" ID="HP:0000815" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008679" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3970" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2687" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">LEYDIG CELL HYPOPLASIA WITH MALE PSEUDOHERMAPHRODITISM</ElementValue>
                <XRef Type="MIM" ID="238320" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LEYDIG CELL HYPOPLASIA, COMPLETE</ElementValue>
                <XRef Type="MIM" ID="238320" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Leydig cell agenesis</ElementValue>
                <XRef ID="Leydig+cells+hypoplasia/4217" DB="Genetic Alliance" />
                <XRef ID="56212008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leydig cell hypoplasia, type 1</ElementValue>
                <XRef ID="MONDO:0009384" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERGONADOTROPIC HYPOGONADISM, MALE, DUE TO LHCGR DEFECT</ElementValue>
                <XRef Type="MIM" ID="238320" DB="OMIM" />
              </Name>
              <XRef ID="C0266432" DB="MedGen" />
              <XRef ID="MONDO:0009384" DB="MONDO" />
              <XRef Type="MIM" ID="238320" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3974" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="11345" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Luteinizing hormone/choriogonadotropin receptor, lq variant</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="3969" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3529" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Familial male-limited precocious puberty</ElementValue>
                <XRef ID="MONDO:0008303" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Testotoxicosis</ElementValue>
                <XRef ID="Testotoxicosis/7032" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TESTOTOXICOSIS, FAMILIAL</ElementValue>
                <XRef Type="MIM" ID="176410" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pubertas Praecox</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial Testotoxicosis (subtype)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Gonadotropin-independent familial sexual precocity</ElementValue>
                <XRef ID="237818003" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4475" />
                <XRef ID="4475" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="3000" DB="Orphanet" />
              <XRef ID="C0342549" DB="MedGen" />
              <XRef ID="MONDO:0008303" DB="MONDO" />
              <XRef Type="MIM" ID="176410" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="744598" SubmissionDate="2016-10-18" DateLastUpdated="2016-12-06" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="562012|Male-Limited Precocious Puberty" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000431077" DateUpdated="2016-12-06" DateCreated="2016-12-06" Type="SCV" Version="2" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-06-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Benign</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification 20161018</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/r4jv4v98/icsl_variant_classification_20161018.pdf</URL>
            <CitationText>ICSL_Variant_Classification_20161018.pdf</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LHCGR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000233.3:c.50_55dupTGCAGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Male-Limited Precocious Puberty</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ICSL_2016Q4</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="744600" SubmissionDate="2016-10-18" DateLastUpdated="2016-12-06" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="562012|Leydig Cell Hypoplasia/Agenesis" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000431079" DateUpdated="2016-12-06" DateCreated="2016-12-06" Type="SCV" Version="2" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-06-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Benign</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification 20161018</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/r4jv4v98/icsl_variant_classification_20161018.pdf</URL>
            <CitationText>ICSL_Variant_Classification_20161018.pdf</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LHCGR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000233.3:c.50_55dupTGCAGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Leydig Cell Hypoplasia/Agenesis</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ICSL_2016Q4</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="744599" SubmissionDate="2016-10-18" DateLastUpdated="2016-12-06" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="562012|Hypergonadotropic Hypogonadism" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000431078" DateUpdated="2016-12-06" DateCreated="2016-12-06" Type="SCV" Version="2" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-06-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Benign</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification 20161018</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/r4jv4v98/icsl_variant_classification_20161018.pdf</URL>
            <CitationText>ICSL_Variant_Classification_20161018.pdf</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LHCGR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000233.3:c.50_55dupTGCAGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <Name>
              <ElementValue Type="Preferred">Hypergonadotropic Hypogonadism</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ICSL_2016Q4</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="644846" SubmissionDate="2016-11-03" DateLastUpdated="2016-12-06" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="11798_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000331441" DateUpdated="2016-12-06" DateCreated="2016-12-06" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-08-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Benign</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions</Attribute>
          <Citation Type="general">
            <URL>http://www.egl-eurofins.com/emvclass/EGLClassificationDefinitions.php</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LHCGR" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="GCTGCA" referenceAllele="-" start="48982755" stop="48982756" variantLength="2" />
            <GeneLocation>NM_000233.3:Ex1</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI035605" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not specified</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://geneticslab.emory.edu/emvclass/emvclass.php?approved_symbol=LHCGR</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL004</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="35747" SubmissionDate="2017-07-18" DateLastUpdated="2017-07-21" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="152790.0017_LUTEINIZING HORMONE/CHORIOGONADOTROPIN RECEPTOR, LQ VARIANT" title="LHCGR, LEU-GLN INS, CODON 19-20_LUTEINIZING HORMONE/CHORIOGONADOTROPIN RECEPTOR, LQ VARIANT" />
        <ClinVarAccession Accession="SCV000035747" DateUpdated="2017-07-21" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Two different human LH receptor sequences have been published, differing by a 6-basepair insertion encoding leu-gln at position 55-60 (Minegishi et al., 1990; Atger et al., 1995). Rodien et al. (1998) demonstrated that both sequences exist as allelic variants in the Caucasian population. Allele frequencies of LQ variant and wildtype allele are 0.26 and 0.74 respectively. In contrast, the LQ allele is virtually absent from the Japanese population. Functional characterization of both alleles by transient expression in COS-7 cells did not reveal any difference between the 2 receptors, neither for cell surface expression nor for cAMP production and sensitivity to CG/LH.</Attribute>
              <Citation>
                <ID Source="PubMed">2244890</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">7556872</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9851790</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Powell et al. (2003) investigated whether functional polymorphic variants in the LH signaling pathway are associated with the risk of breast cancer or its clinical phenotype. Women who were homozygous for the LQ allele were, on average, 8.3 years younger at diagnosis, compared with those homozygous for the wildtype LHR allele (mean age, 51.9 years vs 60.2 years; P = 0.03). Trends were observed for associations between LQ carriers and nodal involvement or larger tumor size. Patients who were LQ carriers revealed a significantly worse overall survival, compared with those who were homozygous for wildtype LHR. The authors concluded that their findings suggested that the LQ gene polymorphism determines an earlier age of disease onset and is prognostic for poor outcome of breast cancer.</Attribute>
              <Citation>
                <ID Source="PubMed">12679452</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LHCGR" />
          </GeneList>
          <Name>LHCGR, LEU-GLN INS, CODON 19-20</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">LEU-GLN INS, CODON 19-20</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="152790.0017" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LUTEINIZING HORMONE/CHORIOGONADOTROPIN RECEPTOR, LQ VARIANT</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1197672" SubmissionDate="2017-08-17" DateLastUpdated="2016-12-06" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="NM_000233.3:c.50_55dup|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000614018" DateUpdated="2016-12-06" DateCreated="2016-12-06" Type="SCV" Version="1" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-07-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Benign</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LHCGR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000233.3:c.50_55dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not specified</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2963629</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1409809" SubmissionDate="2018-03-26" DateLastUpdated="2018-04-09" DateCreated="2018-04-09">
        <ClinVarSubmissionID localKey="GDX:31044|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000728653" DateUpdated="2018-04-09" DateCreated="2018-04-09" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-07-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Benign</GermlineClassification>
          <Comment>This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LHCGR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000233.3:c.55_56insTGCAGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not specified</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3839901</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4629975" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-04-08">
        <ClinVarSubmissionID localKey="1657436|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002401901" DateUpdated="2024-02-20" DateCreated="2022-04-08" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Benign</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LHCGR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.48982755_48982756insGCTGCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11172999</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="744599" TraitType="Finding" MappingType="Name" MappingValue="Hypergonadotropic Hypogonadism" MappingRef="Preferred">
        <MedGen CUI="C0948896" Name="Hypergonadotropic hypogonadism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1409809" TraitType="Disease" MappingType="Name" MappingValue="not specified" MappingRef="Preferred">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="644846" TraitType="Disease" MappingType="Name" MappingValue="not specified" MappingRef="Preferred">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4629975" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="35747" TraitType="Disease" MappingType="Name" MappingValue="LUTEINIZING HORMONE/CHORIOGONADOTROPIN RECEPTOR, LQ VARIANT" MappingRef="Preferred">
        <MedGen CUI="C2750614" Name="Luteinizing hormone/choriogonadotropin receptor, lq variant" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="744600" TraitType="Disease" MappingType="Name" MappingValue="Leydig Cell Hypoplasia/Agenesis" MappingRef="Preferred">
        <MedGen CUI="C0266432" Name="Leydig cell agenesis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1197672" TraitType="Disease" MappingType="Name" MappingValue="not specified" MappingRef="Preferred">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="744598" TraitType="Disease" MappingType="Name" MappingValue="Male-Limited Precocious Puberty" MappingRef="Preferred">
        <MedGen CUI="C0342549" Name="Gonadotropin-independent familial sexual precocity" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

